Effects of synbiotic food consumption on serum minerals, liver enzymes, and blood pressure in patients with type 2 diabetes: A double-blind randomized cross-over controlled clinical trial

Double Blind ◽

Serum Minerals

Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial

Phytotherapy Research ◽

10.1002/ptr.6046 ◽

2018 ◽

Vol 32 (6) ◽

pp. 1073-1079 ◽

Cited By ~ 24

Author(s):

Fatemeh Homayouni ◽

Fatemeh Haidari ◽

Mehdi Hedayati ◽

Mehrnoosh Zakerkish ◽

Kambiz Ahmadi

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Blood Pressure Lowering ◽

Double Blind ◽

Pressure Lowering ◽

Anti Inflammatory

Effect of dietary supplementation with oat β-glucan for 3 months in subjects with type 2 diabetes: A randomized, double-blind, controlled clinical trial

Journal of Functional Foods ◽

10.1016/j.jff.2020.104311 ◽

2021 ◽

Vol 77 ◽

pp. 104311

Author(s):

José Luis Pino ◽

Verónica Mujica ◽

Miguel Arredondo

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Dietary Supplementation ◽

Effects of vitamin D on serum levels and gene expression of enzymes aldose reductase, o-linked n-acetyl glucosamine transferase and glutamine fructose-6-phosphate aminotransferase in patients with type 2 diabetes: a randomized, double blind, placebo controlled clinical trial

International Journal of Food Properties ◽

10.1080/10942912.2021.1879131 ◽

2021 ◽

Vol 24 (1) ◽

pp. 337-345

Author(s):

Mahnaz Zarei ◽

Mohammad Hassan Javanbakht ◽

Hanieh Jafary ◽

Mahmoud Djalali

Keyword(s):

Gene Expression ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Vitamin D ◽

Aldose Reductase ◽

Serum Levels ◽

Double Blind ◽

Double Blind Placebo

Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial

International Journal of Food Sciences and Nutrition ◽

10.1080/09637486.2021.1885015 ◽

2021 ◽

pp. 1-10

Author(s):

Joana Furtado de Figueiredo Neta ◽

Vivian Saraiva Veras ◽

Danilo Ferreira de Sousa ◽

Maria da Conceição dos Santos Oliveira Cunha ◽

Maria Veraci Oliveira Queiroz ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Metabolic Control ◽

Curcuma Longa ◽

Double Blind ◽

Double Blind Placebo

The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2018.09.023 ◽

2018 ◽

Vol 41 ◽

pp. 196-202 ◽

Cited By ~ 9

Author(s):

Alireza Milajerdi ◽

Shima Jazayeri ◽

Elham Shirzadi ◽

Najmeh Hashemzadeh ◽

Atieh Azizgol ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Life Satisfaction ◽

Type 2 Diabetes Mellitus ◽

Alcoholic Extract ◽

Comorbid Depression ◽

A double‐blind placebo‐controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design

Alzheimer s & Dementia Translational Research & Clinical Interventions ◽

10.1002/trc2.12008 ◽

2020 ◽

Vol 6 (1) ◽

Author(s):

Ori BenAri ◽

Shai Efrati ◽

Amir Hadanny ◽

Mary Sano ◽

Barbara B. Bendlin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Oxygen Therapy ◽

Cognitive Outcomes ◽

Cognitively Impaired ◽

Double Blind ◽

Double Blind Placebo ◽

Trial Testing

The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial

Acta Diabetologica ◽

10.1007/s00592-017-1098-3 ◽

2018 ◽

Vol 55 (4) ◽

pp. 341-353 ◽

Cited By ~ 44

Author(s):

ShadiSadat Seyyedebrahimi ◽

Hadi Khodabandehloo ◽

Ensieh Nasli Esfahani ◽

Reza Meshkani

Keyword(s):

Oxidative Stress ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Markers Of Oxidative Stress

Decision letter for "A 24‐week, randomized, double‐blind, active‐controlled clinical trial comparing bexagliflozin to sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults"

10.1111/dom.13801/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Decision letter for "A 24‐week, randomized, double‐blind, active‐controlled clinical trial comparing bexagliflozin to sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults"

10.1111/dom.13801/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Review for "A 24‐week, randomized, double‐blind, active‐controlled clinical trial comparing bexagliflozin to sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults"

10.1111/dom.13801/v1/review2 ◽

2019 ◽

Author(s):

Hungta Chen

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽